Geetha Manjunath

Geetha Manjunath, founder, CEO and CTO of Bengaluru-based Niramai Health Analytix, harnesses artificial intelligence to revolutionise breast cancer detection. With a PhD in AI from IISc and an MBA from Kellogg, her 25-year career spans pioneering AI research at Hewlett-Packard Labs and Xerox, where she led data analytics innovation before charting a new course into healthcare.

Niramai’s flagship Thermalytix technology, radiation-free, portable, and privacy-first, combines thermal imaging with proprietary AI to non-invasively detect early-stage breast cancer, even in women under 45. It’s US FDA and CE‑approved, backed by clinical trials, and has screened over 2.8 lakh women across 200 hospitals.

Her personal connection is profound: losing loved ones to breast cancer motivated her to create a solution rooted in empathy and scientific rigour. An inventor with over 16 US patents and numerous awards, from the CSI Gold Medal to Forbes’ Top 20 Self‑Made Women, Geetha blends deep‑tech brilliance with heartfelt purpose. Whether in labs or remote villages, her AI-driven vision embodies innovation with compassion.